Skip to main content

Prof Charlotte Deane has joined Exscientia as Chief Scientist of Biologics AI. In this newly created role, she will focus on the application of artificial intelligence (AI), machine learning, and the design of protein structures in the discovery and development of novel drug candidates. She will be splitting her time there with her academic role. Her appointment will strengthen the Department’s links with industry. Find out more.

"I'm thrilled to join Exscientia and be part of the mission to revolutionise how new therapeutics are developed. I firmly believe that AI-led strategies are vital to improving all aspects of the process, and we've likely only just seen the beginning of how AI can transform conventional drug discovery and development. I look forward to exploring new frontiers where we can apply this innovation to ultimately bring better medicines to patients, faster.
Charlotte Deane
Related News

Professor Charlotte Deane elected Fellow of the Royal Society

Professor Charlotte Deane MBE, Professor of Structural Bioinformatics in Oxford’s Department of Statistics, has today been announced among the new Fellows of the Royal Society.

OpenBind releases first open dataset and AI model for drug discovery

The OpenBind consortium’s first release of experimental data marks a milestone in efforts to improve how artificial intelligence (AI) is used in drug discovery.

Oxford statisticians take part in PKU–Oxford conference on quantitative finance and data science

Researchers from the University of Oxford’s Department of Statistics were among those taking part in a joint conference with Peking University in April, bringing together academics working across quantitative finance, data science and related areas.